TTO Performance Dashboard
Measure what matters: Revenue, deals, and outcomes - not just patents filed. Prove your value with data.
Financial Performance
Revenue Generated
$3.50M
28% vs last year
Deals Closed
12
Avg: $292K per deal
Portfolio ROI
4.2x
Revenue / Operating Cost
Revenue Sources
Licensing$2.1M
Royalties$0.8M
Equity$0.6M
Strong Financial Performance
Revenue is 25% above peer median. Your TTO is generating $2.92 for every $1 spent.
Pipeline Health
Active Innovations
38
of 45 total
Avg Time to Revenue
18
months from disclosure
Overall Conversion
9%
disclosure to revenue
Stage Conversion Rates
Disclosure → Assessment85%
Assessment → Development65%
Development → Partnering45%
Partnering → Revenue35%
Identified Bottlenecks
- • Partnering stage taking 4+ months
- • Low conversion from development to partnering
Portfolio Performance
Win Rate
27%
12/44 deals closed
Portfolio Value
$28.0M
Projected revenue
Follow-on Funding
$15.0M
Raised by licensees
Jobs Created
156
Economic impact
Average Deal Size
$292K
Per closed deal
Average Time to Close
16
months from first contact
Efficiency Metrics
TTO Operating Cost$1.20M
Cost per Disclosure$27K
Cost per Deal Closed$100K
Revenue per $ Spent$2.92
Staff Utilization87%
Deals per Staff Member3
Benchmarking
Your Ranking
Top 25%
Among peer institutions
Revenue vs. Peers+25%
You: $3.50M | Peer Median: $2.80M
Deals Closed vs. Peers+20%
You: 12 | Peer Median: 10
Portfolio ROI vs. Peers+20%
You: 4.2x | Peer Median: 3.5x
Win Rate vs. Peers+23%
You: 27% | Peer Median: 22%
Why Outcome-Based Metrics Matter
Vanity Metrics (Don't Measure These)
- • Number of patents filed
- • Number of disclosures received
- • Success stories published
- • Number of meetings held
Outcome Metrics (Measure These)
- • Revenue generated (licensing + royalties)
- • Deals closed and portfolio value
- • ROI on TTO operating budget
- • Jobs created and economic impact